Terry Goertz is SVP of Product Management at Aptarro, shaping the future of reimbursement intelligence and AI in revenue cycle management.
Turning data into better decisions is an enduring C-suite priority, but today it happens in an AI-driven environment of unprecedented depth and breadth. Organizations need intelligence systems that can absorb rapidly changing data, distinguish meaningful signals from noise and remain highly reliable as automated systems make more complex decisions at greater speed.
Among the toughest proving grounds for business intelligence at massive scale is healthcare reimbursement, where fragmented data, frequently changing requirements, high-volume operations and the need for specialized domain knowledge all converge. The lessons in this complex market hold true for executives managing similar environments across any industry.
Let’s examine what this demanding environment reveals about decision intelligence in the AI era, and how provider organizations can adopt a data-first approach to reimbursement intelligence that injects more business context and automation into the systems and workflows they already use.
Why Modern Reimbursement Raises The Bar For Decision Intelligence
Claims adjudication is complex in any industry, but nowhere are the requirements, data and consequences more significant than in healthcare. A 2024 analysis of 24.3 million professional claims, including primary care and specialist visits, found that over 20% were denied. This represents substantial friction and major revenue loss for practices, but denials are often only the final and most visible symptom of an earlier intelligence failure.
Payers routinely revise modifier requirements and change policies and procedures; and they’re increasingly adopting AI to scrutinize administrative compliance and clinical care patterns more closely. A provider may not recognize a change in reimbursement trends until weeks later, after similar claims have already entered or exited the same process. By then, what looked like an isolated exception may have become a recurring revenue problem.
It’s clear that providers must modernize to new levels of intelligence to meet this enhanced complexity and payer scrutiny. Payers have seen the value of AI and decision intelligence to their bottom and top lines, and it’s time for healthcare practices to do the same. This ideally happens with a domain-informed data layer that combines payer policy, coding, documentation, specialty context and historical payment behavior. By broadening the scope of knowledge to sector-wide signals, such a reimbursement intelligence layer can uncover subtle shifts and connected events that would otherwise remain invisible within any single organization. While the use of de-identified data to identify patterns across large populations is well established in clinical research and insurance, it has not been applied as broadly to reimbursement intelligence within revenue cycle management.
Building The Reimbursement Intelligence Layer
Reimbursement intelligence must be comprehensive enough to explain both expected conditions and emerging reality. Strong reimbursement intelligence will achieve this with AI models that blend prospective and retrospective intelligence together. Prospective intelligence automates the monitoring of payer bulletins, regulatory guidance and coding updates to identify what is supposed to change. Retrospective intelligence examines recently completed claims, remittances, payment patterns and denials to understand what is actually changing. Comparing both creates a more comprehensive and reliable view than either source alone.
Scale also matters. Within a single organization, emerging reimbursement signals can be difficult to distinguish from noise—and identifying them may require hours of manually combing through data. A broader intelligence network can detect the same signal across multiple organizations, specialties or markets. The advantage comes not from sharing customer records, but from learning broader statistical patterns that make subtle reimbursement shifts easier to recognize and act on before they become significant within any one organization.
The quality of reimbursement intelligence depends not only on the technology, but on the expertise and architecture behind it. Healthcare leaders should look for partners that bring deep clinical, coding and reimbursement expertise to the platform, along with a delivery model that can embed intelligence across the revenue cycle. The goal is to strengthen the systems and workflows teams already use, not introduce another disconnected application or new layer of manual effort.
Investment Criteria And Implementation Priorities
It’s a given that C-suite leaders must prioritize investments that make the most financial and operational sense. In the case of AI-driven reimbursement intelligence, the investment test must extend beyond model performance. It should also include how well the AI fits into existing processes, increases decision velocity, strengthens governance and improves outcomes for practices.
Reducing denials must also begin upstream, well before the claim, where reimbursement risks can still be corrected before submission, protecting revenue and improving cash flow. Reimbursement intelligence integrated as early as possible is critical. Leaders should assess whether the intelligence behind the AI is continually maintained and validated by domain experts, with transparency into its recency, policy sources, transaction data, specialties and reimbursement environments. They should consider how securely that intelligence is managed and whether the system continually compares published requirements with actual claims and remittance outcomes.
Throughout, users should have seamless access to this intelligence layer through the business platforms already in a company’s stack to help validate emerging patterns before they become operational logic. Clear ownership, human oversight and transparent governance further ensure automation outcomes remain trusted, reviewable and aligned with organizational priorities.
From Intelligence To Action
Healthcare reimbursement offers a useful test of what AI-driven reimbursement intelligence should ultimately accomplish: turn complexity into earlier, more informed action. For providers, the measure of success is not the sophistication of the technology itself, but whether it helps prevent avoidable denials and creates more predictable reimbursement. The same principle applies across industries—AI creates value when it helps organizations to recognize what is changing and respond before the consequences compound.
Forbes Technology Council is an invitation-only community for world-class CIOs, CTOs and technology executives. Do I qualify?